International Patient Summary Implementation Guide
1.1.0 - CI Build International flag

International Patient Summary Implementation Guide, published by Health Level Seven International - Patient Care Work Group. This is not an authorized publication; it is the continuous build for version 1.1.0). This version is based on the current content of and changes regularly. See the Directory of published versions

ValueSet: Vaccines WHO ATC - IPS

Official URL: Version: 1.1.0
Standards status: Trial-use Maturity Level: 2 Computable Name: VaccinesWhoAtcUvIps
Other Identifiers: id: 2.16.840.1.113883.11.22.29 (use: OFFICIAL)

Copyright/Legal: This artifact includes content from Anatomical Therapeutic Chemical (ATC) classification system. ATC codes are copyright World Health Organization (WHO) Collaborating Centre for Drug Statistics Methodology. Terms & Conditions in

World Health Organization Anatomical Therapeutic Chemical (ATC) classification system. Note: The currently implemented code system and the value set expansion contain only a set of example ATC codes, not the complete code system content.


This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)



This value set contains 117 concepts

Expansion based on version 2020-05

  J07AC vaccines
  J07AC01 antigen
  J07AD vaccines
  J07AD01 antigen
  J07AE vaccines
  J07AE01, inactivated, whole cell
  J07AE02, live attenuated
  J07AE51, combinations with typhoid vaccine, inactivated, whole cell
  J07AF vaccines
  J07AF01 toxoid
  J07AG influenzae B vaccines
  J07AG01 influenzae B, purified antigen conjugated
  J07AG51 influenzae B, combinations with toxoids
  J07AG52 influenzae B, combinations with pertussis and toxoids
  J07AG53 influenzae B, combinations with meningococcus C, conjugated
  J07AH vaccines
  J07AH01 A, purified polysaccharides antigen
  J07AH02 meningococcal monovalent purified polysaccharides antigen
  J07AH03 A,C, bivalent purified polysaccharides antigen
  J07AH04 A,C,Y,W-135, tetravalent purified polysaccharides antigen
  J07AH05 meningococcal polyvalent purified polysaccharides antigen
  J07AH06 B, outer membrane vesicle vaccine
  J07AH07 C, purified polysaccharides antigen conjugated
  J07AH08 A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
  J07AH09 B, multicomponent vaccine
  J07AH10 A, purified polysaccharides antigen conjugated
  J07AJ vaccines
  J07AJ01, inactivated, whole cell
  J07AJ02, purified antigen
  J07AJ51, inactivated, whole cell, combinations with toxoids
  J07AJ52, purified antigen, combinations with toxoids
  J07AK vaccines
  J07AK01, inactivated, whole cell
  J07AL vaccines
  J07AL01, purified polysaccharides antigen
  J07AL02, purified polysaccharides antigen conjugated
  J07AL52 purified polysaccharides antigen and haemophilus influenzae, conjugated
  J07AM vaccines
  J07AM01 toxoid
  J07AM51 toxoid, combinations with diphtheria toxoid
  J07AM52 toxoid, combinations with tetanus immunoglobulin
  J07AN vaccines
  J07AN01, live attenuated
  J07AP vaccines
  J07AP01, oral, live attenuated
  J07AP02, inactivated, whole cell
  J07AP03, purified polysaccharide antigen
  J07AP10, combinations with paratyphi types
  J07AR (exanthematicus) vaccines
  J07AR01 exanthematicus, inactivated, whole cell
  J07AX bacterial vaccines
  J07BA vaccines
  J07BA01, tick borne, inactivated, whole virus
  J07BA02, Japanese, inactivated, whole virus
  J07BA03, Japanese, live attenuated
  J07BB vaccines
  J07BB01, inactivated, whole virus
  J07BB02, inactivated, split virus or surface antigen
  J07BB03, live attenuated
  J07BB04, virus like particles
  J07BC vaccines
  J07BC01 B, purified antigen
  J07BC02 A, inactivated, whole virus
  J07BD vaccines
  J07BD01, live attenuated
  J07BD51, combinations with mumps, live attenuated
  J07BD52, combinations with mumps and rubella, live attenuated
  J07BD53, combinations with rubella, live attenuated
  J07BD54, combinations with mumps, rubella and varicella, live attenuated
  J07BE vaccines
  J07BE01, live attenuated
  J07BF vaccines
  J07BF01 oral, monovalent, live attenuated
  J07BF02 oral, trivalent, live attenuated
  J07BF03, trivalent, inactivated, whole virus
  J07BF04 oral, bivalent, live attenuated
  J07BG vaccines
  J07BG01, inactivated, whole virus
  J07BH virus diarrhea vaccines
  J07BH01 virus, live attenuated
  J07BH02 virus, pentavalent, live, reassorted
  J07BJ vaccines
  J07BJ01, live attenuated
  J07BJ51, combinations with mumps, live attenuated
  J07BK zoster vaccines
  J07BK01, live attenuated
  J07BK02, live attenuated
  J07BK03, purified antigen
  J07BL fever vaccines
  J07BL01 fever, live attenuated
  J07BM vaccines
  J07BM01 (human types 6, 11, 16, 18)
  J07BM02 (human types 16, 18)
  J07BM03 (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)
  J07BX viral vaccines
  J07BX01 vaccines
  J07BX02 vaccines
  J07CA and viral vaccines, combined
  J07CA04 influenzae B and poliomyelitis
  J07CA05 B-pertussis-tetanus
  J07CA06 influenzae B-pertussis-poliomyelitis-tetanus
  J07CA07 B-tetanus
  J07CA08 influenzae B and hepatitis B
  J07CA09 influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B
  J07CA10 A
  J07CA11 influenzae B-pertussis-tetanus-hepatitis B
  J07CA12 B
  J07CA13 influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code